A study on the role of traditional drug based dressings in the treatment of skin wounds produced in breast cancer patients undergoing radiotherapy
Phase 3
Completed
- Conditions
- Health Condition 1: C508- Malignant neoplasm of overlappingsites of breast
- Registration Number
- CTRI/2020/11/029311
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 110
Inclusion Criteria
1.Patient willing to give written informed consent form
2. Newly diagnosed with non metastatic breast cancer and undergoing adjuvant radiation for breast cancer who develop grade III radiation therapy induced moist desquamation
Exclusion Criteria
1.Patient unwilling to take part in study
2.Patients with contraindications for Radiation therapy
3.Patients with radiation skin reactions of severity less than Grade III
4.Patients with pre existing skin conditions such as psoriasis, eczema, or connective tissue disorders or history of allergy to components used in trial dressings
5.Patients on steroids or immunosuppressant therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br/ ><br>To assess tolerance of Acalypha indica impregnated thin film on radiated tissue <br/ ><br>Timepoint: 4th to 6th week of radiation treatment for each patient.
- Secondary Outcome Measures
Name Time Method To assess wound healing capacity of Acalypha indica impregnated thin film on radiation induced dermatitis wounds with respect to time taken for complete wound healing in comparison to gentian violet topical application. <br/ ><br>To assess improvement in quality of life of patientsTimepoint: Upto 6 months after completion of radiation protocol of last recruited patient